Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear

Details for Australian Patent Application No. 2006295248 (hide)

Owner Piedmont Pharmaceuticals LLC

Inventors Campbell, William R.; Paulsen, Neil E.; Johnson, Roland H.

Agent Freehills

Pub. Number AU-A-2006295248

PCT Pub. Number WO2007/037886

Priority 60/720,536 26.09.05 US

Filing date 25 August 2006

Wipo publication date 5 April 2007

International Classifications

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/037886 Priority application(s): WO2007/037886

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006295256-Intraocular pressure control

2006295245-Handheld communication tester and method for testing direct serial communication capability of an intelligent electronic device in a power system